David Centurión Selected Research

David Centurión Research Topics

Disease

8	Migraine Disorders (Migraine) 10/2015 - 03/2003
4	Hypertension (High Blood Pressure) 01/2022 - 10/2007
3	Hypotension (Low Blood Pressure) 01/2016 - 10/2004
3	Tachycardia (Tachyarrhythmias) 02/2009 - 03/2002
2	Neuralgia (Stump Neuralgia) 04/2022 - 01/2019
2	Hyperalgesia 04/2022 - 01/2019
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2022
2	Non-alcoholic Fatty Liver Disease 11/2019 - 01/2019
2	Fatty Liver 11/2019 - 01/2019
2	Fibrosis (Cirrhosis) 11/2019 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 09/2019 - 11/2017
2	Insulin Resistance 01/2019 - 11/2017
1	Hypothyroidism 01/2020
1	Body Weight (Weight, Body) 11/2019
1	Diarrhea 11/2019
1	Obesity 11/2019
1	Hypersensitivity (Allergy) 01/2019
1	Pain (Aches) 01/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019
1	Reperfusion Injury 03/2018
1	Ischemia 03/2018
1	Hyperinsulinism (Hyperinsulinemia) 11/2017
1	Intracranial Vasospasm 03/2011
1	Pre-Eclampsia (Preeclampsia) 11/2008
1	Bradycardia 10/2007
1	Heart Failure 10/2007
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2007

Drug/Important Bio-Agent (IBA)

7	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 03/2002
5	Calcitonin Gene-Related PeptideIBA 10/2015 - 08/2006
4	Metformin (Glucophage)FDA LinkGeneric 11/2019 - 11/2017
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 03/2018
2	Serotonin ReceptorsIBA 01/2020 - 10/2007
2	Sucrose (Saccharose)IBA 11/2019 - 01/2019
2	sodium bisulfide (NaHS)IBA 11/2019 - 01/2016
2	FructoseIBA 01/2019 - 11/2017
2	Adrenergic Agents (Adrenergic Drugs)IBA 11/2017 - 10/2008
2	Capsaicin (Zostrix)FDA Link 10/2015 - 05/2012
2	Ergotamine (Ergotamine Tartrate)FDA LinkGeneric 09/2013 - 02/2009
2	Tryptamines (Triptans)IBA 10/2008 - 03/2003
2	5-HT2 Serotonin ReceptorsIBA 10/2007 - 03/2002
1	tizanidine (Zanaflex)FDA LinkGeneric 04/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 04/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2020
1	propargylglycineIBA 11/2019
1	4-hydroxychalconeIBA 11/2019
1	CholesterolIBA 11/2019
1	Cysteine (L-Cysteine)FDA Link 11/2019
1	Therapeutic UsesIBA 11/2019
1	Pharmaceutical PreparationsIBA 09/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Drinking WaterIBA 01/2019
1	Diclofenac (SR 38)FDA LinkGeneric 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Insulin ReceptorIBA 01/2019
1	GasotransmittersIBA 03/2018
1	Methoxamine (Methoxamine Hydrochloride)FDA Link 11/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2017
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 11/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 10/2015
1	Testosterone (Sustanon)FDA Link 03/2011
1	5-HT1B Serotonin ReceptorIBA 11/2008
1	Hormones (Hormone)IBA 10/2008
1	Kainic Acid (Kainate)IBA 10/2008
1	Adenosine (Adenocard)FDA LinkGeneric 10/2008
1	Dopamine (Intropin)FDA LinkGeneric 10/2008
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2008
1	Estrogens (Estrogen)FDA Link 10/2008
1	N-Methylaspartate (NMDA)IBA 10/2008
1	Endothelins (Endothelin)IBA 10/2008
1	Sumatriptan (Imigran)FDA LinkGeneric 10/2008
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 10/2008
1	Glutamic Acid (Glutamate)FDA Link 10/2008
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 10/2008
1	pyrrolidineIBA 10/2004
1	5-carboxamidotryptamineIBA 10/2004
1	SB 269970IBA 10/2004
1	1- (5- (2- thenyloxy)- 1H- indol- 3- yl)propan- 2- amineIBA 10/2004
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2003
1	Vasoconstrictor AgentsIBA 03/2003
1	LY 344864IBA 03/2003
1	KetanserinIBA 03/2002
1	TyramineIBA 03/2002
1	4-iodo-2,5-dimethoxyphenylisopropylamine (DOI-P)IBA 03/2002
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2002
1	Ro 60-0175IBA 03/2002

Therapy/Procedure

1	Ligation 04/2022
1	Injections 11/2017
1	Therapeutics 10/2008
1	Intravenous Injections 10/2004